Consort's nicotine delivery device deal with BAT to be "largest single revenue opportunity"
This article was originally published in Clinica
Executive Summary
UK drug delivery device specialist Consort Medical this morning announced its subsidiary Bespak has struck a multi-year contract to be the exclusive supplier of an innovative nicotine inhalation device for Nicoventures, a unit within the world's number two tobacco player, the giant British American Tobacco. The product incorporates Bespak's proprietary valve, and is designed to be a safer alternative to smoking.